SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-387295"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-387295" > Efficacy and safety...

  • Guimaraes, Patricia O.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair : Insights from the ARISTOTLE trial

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • 2019-04-09
  • Wiley,2019
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-387295
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-387295URI
  • https://doi.org/10.1002/clc.23178DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background The optimal anticoagulation strategy for patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement or native valve repair remains uncertain.HypothesisWe evaluated the safety and efficacy of apixaban vs warfarin in patients with AF and a history of BPV replacement or native valve repair.MethodsUsing data from Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) (n = 18 201), a randomized trial comparing apixaban with warfarin in patients with AF, we analyzed the subgroup of patients (n = 251) with prior valve surgery. We contacted sites by telephone to obtain additional data about prior valve surgery. Full data were available for 156 patients. The primary efficacy endpoint was stroke/systemic embolism. The primary safety endpoint was major bleeding. Treatment groups were compared using a Cox regression model.ResultsIn ARISTOTLE, 104 (0.6%) patients had a history of BPV replacement (n = 73 [aortic], n = 26 [mitral], n = 5 [mitral and aortic]) and 52 (0.3%) had a history of valve repair (n = 50 [mitral], n = 2 [aortic]). Among patients with BPVs, 55 were randomized to apixaban and 49 to warfarin. Among those with a history of native valve repair, 32 were randomized to apixaban and 20 to warfarin. Overall clinical event rates were low, with no significant differences between apixaban and warfarin for any outcomes.ConclusionsIn patients with AF and a history of BPV replacement or repair, the safety and efficacy of apixaban compared with warfarin was consistent with results from ARISTOTLE. These data suggest that apixaban may be reasonable for patients with BPVs or prior valve repair, though future larger randomized trials are needed.ClinicalTrials.govNCT00412984.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Pokorney, Sean D.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Lopes, Renato D.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Wojdyla, Daniel M.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Gersh, Bernard J.Mayo Clin, Div Cardiovasc Dis, Coll Med, Rochester, MN USA (författare)
  • Giczewska, AnnaDuke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA;Gdansk Univ Technol, Dept Biomed Engn, Fac Elect Telecommun & Informat, Gdansk, Poland (författare)
  • Carnicelli, AnthonyDuke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Lewis, Basil S.Lady Davis Carmel Med Ctr, Dept Cardiovasc Med, Haifa, Israel (författare)
  • Hanna, MichaelBristol Myers Squibb, Princeton, NJ USA (författare)
  • Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall (författare)
  • Vinereanu, DragosUniv & Emergency Hosp, Dept Cardiol, Univ Med & Pharm Carol Davila, Bucharest, Romania (författare)
  • Alexander, John H.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Granger, Christopher B.Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA (författare)
  • Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USAMayo Clin, Div Cardiovasc Dis, Coll Med, Rochester, MN USA (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Clinical Cardiology: Wiley42:5, s. 568-5710160-92891932-8737

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy